We are live on
!
Find out more
Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘21 |
|
|---|---|---|---|---|---|
| $120K | $120K | $0 | 212% |
|
|
| $119K | $231K | $112K | 98.9% |
|
|
| $117K | $798K | $681K | 9.78% |
|
|
|
CLLS
2004
Cellectis
CLLS
$301M
| $116K | $559K | $443K | 76.3% |
|
| $115K | $283K | $168K | 151% |
|
|
| $113K | $3.4M | $3.29M | 71.7% |
|
|
| $113K | $202K | $89K | 91.4% |
|
|
| $112K | $1.01M | $894K | 31.8% |
|
|
| $111K | $671K | $560K | 31.3% |
|
|
| $109K | $605K | $496K | 59.9% |
|
|
2011
VYNE Therapeutics
VYNE
$21.3M
| $108K | $140K | $32K | 97.5% |
|
| $107K | $227K | $120K | 357% |
|
|
| $105K | $1.38M | $1.27M | 100% |
|
|
| $105K | $127K | $22K | 137% |
|
|
| $104K | $2.85M | $2.75M | 5.18% |
|
|
| $104K | $195K | $91K | 59.7% |
|
|
| $102K | $456K | $354K | 100% |
|
|
| $102K | $102K | $0 | 184% |
|
|
| $100K | $319K | $219K | 673% |
|
|
| $99K | $956K | $857K | 90.1% |
|
|
| $98K | $98K | $0 | 66.3% |
|
|
| $97K | $1.55M | $1.46M | 3.71% |
|
|
| $97K | $339K | $242K | 65.9% |
|
|
| $95K | $3.63M | $3.54M | 20.3% |
|
|
| $95K | $232K | $137K | 19.3% |
|